Pathak Keshav Kumar, Dalai Richie, Ghorui Arnab, Chowdhary Bhabesh Kant
Department of Neonatology, All India Institute of Medical Sciences, Patna, Patna, India.
Matern Health Neonatol Perinatol. 2025 Sep 2;11(1):27. doi: 10.1186/s40748-025-00229-4.
There are currently no specific guidelines for neonatal dengue. The available guidelines focus on the pediatric age group. The objective of this study is to summarize the clinical presentations and management strategies, based on the available studies in literature and to report another case of neonatal dengue.
The PUBMED and Scopus databases were searched using "neonate", "dengue", and their synonyms as the search terms. We included observational studies of suspected or proven cases of neonates with dengue infection, irrespective of their gestational age and birth weight. The studies were screened for possible inclusion in the review by two independent reviewers. The neonates that died in hospital among the reported cases were compared with those that survived till discharge, for reported baseline variables, using chi-square/fisher's exact test, Wilcoxon-Rank Sum test, and multivariable logistic regression.
A total of 57 observational studies on neonatal dengue were found. Of these, 41 were case reports of single cases, 15 were case series of 2 or more cases and 1 was a cohort study. These included a total of 144 cases apart from our reported case. The most common clinical manifestations were thrombocytopenia (81.69%), fever (61.97%), rash (45.07%), and organomegaly (29.58%). Supportive care with fluids and platelet transfusion for severe thrombocytopenia were the mainstay of therapy. Most neonates (94.4%), improved after a week of onset of symptoms with median and interquartile range (IQR) of 7 (6-10) days. Only 8 neonatal dengue deaths were reported in the available literature. When compared with those who survived till discharge, except for third spacing (p-value = 0.001), none of the other baseline clinical parameters were found to be significantly different. On multivariable logistic regression analysis, for those factors with p-value < 0.2 in univariate analysis, none of the factors had an independent association with the outcome of death in neonatal dengue cases. Our index case also presented with high-grade fever on day 5 of life, petechial rash and thrombocytopenia on day 6 of life and improved by day 7 of illness with supportive care.
Neonatal dengue has a good prognosis as per the cases reported in the literature. None of the clinical parameters were found to be independently associated with neonatal mortality in the reported cases of neonatal dengue in literature. Further prospective observational studies will be needed to find the true predictors of poor outcomes in neonates with dengue infection.
目前尚无针对新生儿登革热的具体指南。现有的指南主要侧重于儿童年龄组。本研究的目的是根据文献中的现有研究总结临床表现和管理策略,并报告另一例新生儿登革热病例。
使用“新生儿”、“登革热”及其同义词作为检索词,对PUBMED和Scopus数据库进行检索。我们纳入了对疑似或确诊的新生儿登革热感染病例的观察性研究,无论其胎龄和出生体重如何。由两名独立的评审员对这些研究进行筛选,以确定是否可能纳入本综述。对于报告的基线变量,使用卡方检验/费舍尔精确检验、威尔科克森秩和检验和多变量逻辑回归,对报告病例中在医院死亡的新生儿与存活至出院的新生儿进行比较。
共发现57项关于新生儿登革热的观察性研究。其中,41项为单例病例报告,15项为2例或更多病例的病例系列,1项为队列研究。除我们报告的病例外,这些研究共包括144例病例。最常见的临床表现为血小板减少(81.69%)、发热(61.97%)、皮疹(45.07%)和器官肿大(29.58%)。针对严重血小板减少症进行液体支持治疗和血小板输注是主要的治疗方法。大多数新生儿(94.4%)在症状出现一周后病情改善,中位时间和四分位间距(IQR)为7(6 - 10)天。现有文献中仅报告了8例新生儿登革热死亡病例。与存活至出院的新生儿相比,除第三间隙(p值 = 0.001)外,未发现其他基线临床参数有显著差异。在多变量逻辑回归分析中,对于单变量分析中p值 < 0.2的那些因素,没有一个因素与新生儿登革热病例的死亡结局有独立关联。我们的索引病例在出生后第5天出现高热,并在出生后第6天出现瘀点皮疹和血小板减少,经支持治疗后在发病后第7天病情改善。
根据文献报道的病例,新生儿登革热预后良好。在文献报道的新生儿登革热病例中,未发现任何临床参数与新生儿死亡率有独立关联。需要进一步进行前瞻性观察研究,以找出登革热感染新生儿不良结局的真正预测因素。